World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 1286348

Number of visits today: 22

Number of downloads: 871318

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Yang Y, Xu J, Zhang Q. Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B. Oncol Lett 2018;15:7923-33. [PMID: 29725479 DOI: 10.3892/ol.2018.8317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]

For:

Yang Y, Xu J, Zhang Q. Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B. Oncol Lett 2018;15:7923-33. [PMID: 29725479 DOI: 10.3892/ol.2018.8317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]

Number	Citing Articles
1	Jin F, Shahid M, Kim J. Research Progress of Urine Biomarkers in the Diagnosis, Treatment, and Prognosis of Bladder Cancer. Adv Exp Med Biol 2021;1306:61-80. [PMID: 33959906 DOI: 10.1007/978-3-030-63908-2_5] [Reference Citation Analysis]
2	Santoni G, Morelli MB, Amantini C, Battelli N. Urinary Markers in Bladder Cancer: An Update. Front Oncol 2018;8:362. [PMID: 30245975 DOI: 10.3389/fonc.2018.00362] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
3	Gruba N, Stachurski L, Lesner A. Chemical tools to monitor bladder cancer progression. Biomarkers 2022;:1-41. [PMID: 35532038 DOI: 10.1080/1354750X.2022.2076153] [Reference Citation Analysis]
4	Wang ZX, Guo MY, Ren J, Li GS, Sun XG. Identification of Lysosome-Associated Protein Transmembrane-4 as a Novel Therapeutic Target for Osteosarcoma Treatment. Orthop Surg 2020;12:1253-60. [PMID: 32558212 DOI: 10.1111/os.12692] [Reference Citation Analysis]
5	Humayun-Zakaria N, Ward DG, Arnold R, Bryan RT. Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein? Transl Androl Urol 2021;10:2787-808. [PMID: 34295762 DOI: 10.21037/tau-20-1327] [Reference Citation Analysis]
6	Lucca I, Hofbauer SL, Haitel A, Susani M, Shariat SF, Klatte T, De Martino M. Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria. Oncol Lett 2019;18:57-62. [PMID: 31289472 DOI: 10.3892/ol.2019.10330] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7	Kim J, Jin P, Yang W, Kim WJ. Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist. Investig Clin Urol 2020;61:539-54. [PMID: 33135400 DOI: 10.4111/icu.20200317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]